Colombia Detects First H3N2 K Subclade Case Following Global Alerts

Building on international alerts, Colombia's Ministry of Health confirmed the first case of influenza A(H3N2) subclade K in a traveler with mild symptoms. Officials are monitoring this seasonal variant, with pediatric experts urging enhanced prevention amid peak transmission risks for children.

Colombia's Ministry of Health and Social Protection announced the first confirmed case of influenza A(H3N2) subclade K, detected via molecular tests by the National Institute of Health (INS). The patient presented mild respiratory symptoms and recent international travel history, consistent with patterns seen in global spread reported earlier in Europe, the US, and Latin American surveillance.

Authorities are tracking influenza A subtypes like A(H1N1)pdm09 and A(H3N2), which peak seasonally between May-June and September-November. This detection follows broader alerts on the K subclade's circulation abroad.

Dr. Catalina Vásquez, Pediatric Pulmonology coordinator at Hospital Infantil Universitario de San José in Cali, highlights risks for children under three and those with chronic conditions like asthma or diabetes. 'Infections can progress to severe pneumonia, especially in young children,' she warns, advising prompt care for symptoms such as breathing difficulty, persistent fever, or lethargy.

Recommendations include annual vaccination for children under three, seniors over 60, pregnant women, chronically ill individuals, and healthcare workers, alongside handwashing, ventilation, and breastfeeding. 'Timely prevention is key during peak seasons,' Dr. Vásquez emphasizes.

This case reinforces the need for vigilance to curb complications in vulnerable groups.

関連記事

Realistic illustration of Indonesian doctors treating super flu patients in a Bandung hospital, with Java map highlighting affected areas, conveying controlled outbreak.
AIによって生成された画像

Super flu cases detected in Central and West Java

AIによるレポート AIによって生成された画像

Central Java's Health Department detected one case of super flu, or influenza A H3N2 subclade K, in Semarang at the end of December 2025. Meanwhile, Hasan Sadikin Hospital in Bandung confirmed 10 cases in West Java from August to November 2025, with one patient dying due to comorbidities. Health officials stress that this is not a new virus and the situation is under control.

A mutation of the influenza A virus, known as the H3N2 K subclade, has led to increased hospitalizations in Europe and the United States, though no more severe cases are reported. In Latin America, including Mexico, preventive surveillance is in place without this variant predominating. Authorities recommend vaccination for vulnerable groups amid the risk of spread.

AIによるレポート

Chile's Ministry of Health, through the Public Health Institute, confirmed the detection of the first cases of influenza A (H3N2) sub-clade K, known as “supergripe”, in analyzed samples in the country. This finding was expected given the virus's global behavior, already detected in Brazil and Peru. Health Minister Ximena Aguilera clarified that it is not a new virus or a pandemic.

Influenza has truly arrived in Sweden. In the first week of the year, 2,131 cases were confirmed, a 22 percent increase from the end of the previous week. The spread is assessed as medium-high level, according to the Public Health Agency.

AIによるレポート

米国は2025年、ウイルスによる初の人間死亡後、鳥インフルエンザ流行を食い止め、7月までに公衆衛生緊急対応を終了した。進展はあるものの、専門家はH5N1株が動物への脅威を残し、人間へのリスクも依然としてあると警告している。検査、ワクチン研究、生体セキュリティ対策に焦点を当てた取り組みが、家畜と人間の症例を減少させた。

Hong Kong is approaching the winter flu season, but vaccination rates among most age groups remain below the 70 per cent threshold needed for herd immunity, a leading government medical adviser has warned. David Hui Shu-cheong on Saturday reminded the public to get vaccinated ahead of Lunar New Year, when social gatherings are frequent.

AIによるレポート

広域抗体を投与する鼻スプレーが、動物および予備的人間試験で、あらゆるインフルエンザ株からの感染を防ぐ可能性を示した。Johnson & Johnsonが当初開発し、現在Leyden Labsが推進するこのスプレーは、パンデミック時に迅速な保護を提供できる可能性がある。専門家は、高リスクグループ向けの貴重なツールと見なしつつ、さらなる試験が必要と指摘している。

 

 

 

このウェブサイトはCookieを使用します

サイトを改善するための分析にCookieを使用します。詳細については、プライバシーポリシーをお読みください。
拒否